A genome‐wide analysis in high and low‐expressing cell lines identified quite significant expression differences in the role of PRMT5 on both transcription and RNA splicing activity.
← all excerpts
Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma.
1
—
—